Professional Documents
Culture Documents
Arbini
1) What is it it?
2) Tools for Dx?
3) Lineage?
4) APML ~ AML: pathophysiology
Leukemia (Acute)
032311 - Arbini
To do: [slide 5]
AML = acute myeloid leukemia, B-ALL = b lymphoblastic leukemia, T-ALL = t lymphoblastic leukemia
PNH = paroxysmal nocturnal hemoglobiuria
IHC = immunohistochemistry
what is leukemia?
dx?
linae of aculte leukemia
patho of acute myelocytic leumia as model of myeloid leukemia
What is leukemia?
- abnormal hematopoeitic tissue initiated by a leukemic stem cell - aberrant, poorly regulated
organogenesis
What is leukemia?
Newly formed, abnormal hematopoietic tissue initaed by leukemic stem cell -> aberrant
organogenesis
Stem cell : precursor -> hematopoietic tissue
o Non random somatic chromosomal translocation -> target TF’s
What is clonality?
>>A single cell has a genetic lesion that allows it to become a neoplastic cell that can reproduce
indefinitely, giving rise to other cell which are exact copies. All cells of a leukemia are clonal: arose from
a single cell and have same charcter, genotype, and immunophenotype.
[Slide 5]
Cell Lineages:
Hematopoietic stem cells (self preserving, mitosis/2mo)
Dx?
- morphologically: blood/bone marrow smears
- flow cytometry (show expansion of a cell population -> CLONALITY)
- genotypically - abnormsal karyotype (translocations, additions, deletions)
- molecularly: DNA mutatios, cell clonality
Flow cytometry: uses fluorescently labeled antibodies, while the cytometer detects particular colors and
wavelengths through a ystem of mirrors and detectors -> determine how many/which celsl have what
surface markers (CD’s). most common tool for dx of MYELOID / LYMPHOID LEUKEMIA.
======
AML = acute myeloid leukemia
who: young vs old (single lesion -> TF vs. complex genetic lesion), mostly sporadic
congenital d/o inc risk:
Fanconi (BRCA2)
Bloom (DNA helicase)
Down (Trisomy 21)
Kostmann (neutorphil elastase -> apoptois of myeloid precursors)
Shwachman-Diamond (ribosomal biogenes / myeloid precursors)
acquired hematologic d/o: chronic myeloproliferative, myelodysplastic neoplasmas, PNH
genetic damage: radiation, benzene
Classification of AML:
w/ recurrent genetic abnormalities
o APML (acute promyelocytic leukemia) – model of AML t(15;17)
o AML – t(8;21)
o AML w/ abnormal eosinopils inv(16)
w/ myelodysplasia related changes (prior myeloid dysplasia)
& MDS – tx related (chemo alkylating -> DNA damage -> inc’d risk, worse prognosis)
NOS (50% unknown)
Causes of AML (032311_Raphael)
Impaired differentiation, self-renewing stem cells, heterogeneity (tumors can change with time)
Origin of APML?
Promyelocytes – only leukemia to arise from; most come from myelocytes
University of
Minnesota
Summary Comments
Genetics T(15;17) of PML gene and retinoid Translocation of PML gene (chr 15) and
receptor retinoid receptor (chr 17)
Summary Comments
Who? Kids < 5 (75%)
Presents? Leukemia (85%) Leukemia: bone marrow involvement;
Lymphoblastic lymphoma (10%, rare) spleen, liver, gonads, CNS
Histo Blasts Undifferentiated hematopoetic cell
clusters w/ loose chromatin
Prognosis Good: t(12;21), > 49 chromsomes Cytogenetic abnromalities are crucial for
Bad: everything else prognosis: 21 is good!
Summary Comments
Who Teens, young adults
Presents Mediastinal mass Bc tcells mature in thymus!
Dx / Markers T-cell markers: variable Only t-lymphocytes in thymus have CD1a.,
CD3- surface, + in cytoplasm
CDa1, TdT = immature t-
lymphocytes
Flow cytometry
CD 34 = immature marker